Phase transition of WTAP regulates m A modification of interferon-stimulated genes

Sihui Cai,Jie Zhou,Xiaotong Luo,Chenqiu Zhang,Shouheng Jin,Jian Ren,Jun Cui
DOI: https://doi.org/10.1101/2024.07.18.604157
2024-07-22
Abstract:-methyladenosine (m A) is the most prevalent modification of mRNA which controls diverse physiological processes. Although m A modification is reported to regulate type I interferon (IFN) responses by targeting the mRNA of IFN-β and the interferon stimulated genes (ISGs), the detailed mechanism of how m A methyltransferase complex (MTC) responses quickly to conduct the modification on nascent mRNA co-transcriptionally during IFN-β stimulation remains largely unclear. Here, we demonstrate that WTAP, the adaptor protein of m A MTC, goes through dephosphorylation regulated phase transition from aggregates to liquid droplets under IFN-β stimulation. Phase transition of WTAP mediates the m A modification of a subset of ISGs mRNA to restrict their expression. In mechanism, we found that formation of aggregates prevents WTAP from binding on the promoter region of ISGs or conducting m A modification on mRNA in untreated cells. while IFN-β induced WTAP droplets interacts with nucleus-translocated transcriptional factor STAT1 and recruits MTC on the promoter region of ISGs, directing the co-transcriptional m A modification on ISGs mRNA. Collectively, our findings reveal a novel regulatory role of WTAP phase transition under viral infection to orchestrate dynamic m A modification with the cooperation of transcriptional factors and MTC, and precisely manipulate signaling pathway.
Immunology
What problem does this paper attempt to address?
The paper primarily explores how the phase transition of WTAP (Wilm’s Tumor Associated Protein) under interferon-β (IFN-β) stimulation regulates the mechanism of m6A (N6-methyladenosine) modification on interferon-stimulated genes (ISGs). Specifically, the paper addresses the following key issues: 1. **Drivers of WTAP phase transition**: The study found that WTAP undergoes a phase transition from aggregates to droplets under IFN-β stimulation, revealing that this process is driven by IFN-β-induced dephosphorylation. 2. **Impact of WTAP phase transition on m6A modification**: The paper shows that the liquid phase state of WTAP promotes m6A modification of specific ISGs mRNA, thereby regulating the expression levels of these genes. 3. **Interaction between WTAP, transcription factors, and the m6A methyltransferase complex (MTC)**: The research indicates that under IFN-β stimulation, WTAP interacts with the transcription factor STAT1 to recruit MTC to the promoter regions of ISGs, guiding the m6A modification of ISGs mRNA. 4. **Functional differences of WTAP in different states**: The paper compares the functional differences of WTAP in its aggregated and liquid phase states, emphasizing the importance of liquid phase WTAP for m6A modification. In summary, this study reveals how WTAP phase transition acts as a bridge connecting transcription factors and the m6A methyltransferase complex to precisely regulate the dynamic changes of m6A modification in antiviral immune responses. This provides new insights into the regulatory mechanisms of m6A modification in antiviral immune responses.